Barclays PLC Celcuity Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Celcuity Inc. stock. As of the latest transaction made, Barclays PLC holds 53,605 shares of CELC stock, worth $670,598. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,605

Previous 53,605 -0.0%

Holding current value

$670,598

Previous $800,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$13.98 - $19.15 $637,152 - $872,780	45,576 Added 567.64%	53,605 $800,000
Q2 2024 Aug 14, 2024	SELL	$14.1 - $20.78 $67,891 - $100,055	-4,815 Reduced 37.49%	8,029 $131,000
Q1 2024 May 15, 2024	SELL	$13.74 - $21.6 $153,571 - $241,423	-11,177 Reduced 46.53%	12,844 $277,000
Q4 2023 Feb 15, 2024	BUY	$8.7 - $15.02 $181,220 - $312,866	20,830 Added 652.77%	24,021 $350,000
Q3 2023 Nov 07, 2023	SELL	$8.96 - $10.75 $2,329 - $2,795	-260 Reduced 7.53%	3,191 $30,000
Q2 2023 Aug 03, 2023	BUY	$9.39 - $12.18 $32,404 - $42,033	3,451 New	3,451 $37,000
Q2 2022 Aug 12, 2022	SELL	$5.35 - $10.11 $8,217 - $15,528	-1,536 Reduced 97.77%	35 $0
Q1 2022 May 16, 2022	SELL	$7.93 - $13.33 $80,600 - $135,486	-10,164 Reduced 86.61%	1,571 $14,000
Q4 2021 Feb 14, 2022	BUY	$11.96 - $19.35 $93,096 - $150,620	7,784 Added 197.01%	11,735 $154,000
Q3 2021 Nov 09, 2021	BUY	$17.35 - $24.87 $51,043 - $73,167	2,942 Added 291.58%	3,951 $71,000
Q2 2021 Aug 13, 2021	BUY	$14.25 - $30.93 $9,975 - $21,651	700 Added 226.54%	1,009 $24,000
Q1 2021 May 13, 2021	BUY	$10.43 - $17.8 $3,222 - $5,500	309 New	309 $4,000
Q3 2020 Nov 12, 2020	SELL	$5.1 - $7.07 $8,593 - $11,912	-1,685 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$4.42 - $11.04 $1,113 - $2,782	-252 Reduced 13.01%	1,685 $12,000
Q1 2020 May 13, 2020	SELL	$5.79 - $11.78 $22,858 - $46,507	-3,948 Reduced 67.09%	1,937 $13,000
Q4 2019 Feb 10, 2020	BUY	$9.47 - $16.71 $28,277 - $49,896	2,986 Added 103.0%	5,885 $63,000
Q3 2019 Nov 14, 2019	SELL	$15.74 - $23.65 $14,087 - $21,166	-895 Reduced 23.59%	2,899 $49,000
Q2 2019 Aug 14, 2019	BUY	$19.88 - $25.0 $42,781 - $53,800	2,152 Added 131.06%	3,794 $95,000
Q1 2019 May 15, 2019	BUY	$18.38 - $24.44 $30,179 - $40,130	1,642 New	1,642 $36,000
Q4 2018 Feb 14, 2019	SELL	$20.87 - $29.05 $45,454 - $63,270	-2,178 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$20.96 - $30.77 $36,742 - $53,939	1,753 Added 412.47%	2,178 $63,000
Q2 2018 Aug 14, 2018	SELL	$16.13 - $26.99 $5,258 - $8,798	-326 Reduced 43.41%	425 $10,000
Q1 2018 May 15, 2018	BUY	$13.55 - $21.3 $4,186 - $6,581	309 Added 69.91%	751 $12,000
Q4 2017 Feb 14, 2018	BUY	$12.12 - $21.65 $5,357 - $9,569	442	442 $8,000

Others Institutions Holding CELC

# of Institutions

105

Shares Held

30.4M

Call Options Held

30.8K

Put Options Held

152K

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $187M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account